Myrexis Inc Cmn Stk
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
Myrexis Inc Cmn Stk (MYRX) - Total Liabilities
Latest total liabilities as of June 2013: $74.00K USD
Based on the latest financial reports, Myrexis Inc Cmn Stk (MYRX) has total liabilities worth $74.00K USD as of June 2013.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Myrexis Inc Cmn Stk - Total Liabilities Trend (2008–2013)
This chart illustrates how Myrexis Inc Cmn Stk's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Myrexis Inc Cmn Stk Competitors by Total Liabilities
The table below lists competitors of Myrexis Inc Cmn Stk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WEST WITS MIN
BE:4W3
|
Germany | €3.10 Million |
|
Atlantic Energy Solutions Inc
PINK:AESO
|
USA | $25.40K |
|
daVictus plc
LSE:DVT
|
UK | GBX242.58K |
|
The Income & Growth VCT
LSE:IGV
|
UK | GBX413.19K |
|
Us1 Critical Minerals Limited
AU:USC
|
Australia | AU$168.75K |
|
Armadale Capital Plc
LSE:ACP
|
UK | GBX73.00K |
Liability Composition Analysis (2008–2013)
This chart breaks down Myrexis Inc Cmn Stk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 16.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Myrexis Inc Cmn Stk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Myrexis Inc Cmn Stk (2008–2013)
The table below shows the annual total liabilities of Myrexis Inc Cmn Stk from 2008 to 2013.
| Year | Total Liabilities | Change |
|---|---|---|
| 2013-06-30 | $74.00K | -96.75% |
| 2012-06-30 | $2.28 Million | -31.15% |
| 2011-06-30 | $3.31 Million | -22.12% |
| 2010-06-30 | $4.25 Million | -7.12% |
| 2009-06-30 | $4.58 Million | -90.17% |
| 2008-06-30 | $46.57 Million | -- |